Search Results - "Weber, Martin"

Refine Results
  1. 1

    Can International Relations (IR) learn? The politics of 'doing understanding' by Weber, Martin

    “…This short response considers some challenges that may be faced by learners keen to engage with 'Indigenous International Relations' following the lecture by…”
    Get full text
    Journal Article
  2. 2

    Toward identifying key mechanisms of progression in multiple sclerosis by Husseini, Leila, Geladaris, Anastasia, Weber, Martin S

    Published in Trends in neurosciences (Regular ed.) (01-01-2024)
    “…A major therapeutic goal in the treatment of multiple sclerosis (MS) is to prevent the accumulation of disability over an often decades-long disease course…”
    Get full text
    Journal Article
  3. 3

    Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors: A Review by Dybowski, Sarah, Torke, Sebastian, Weber, Martin S

    Published in JAMA neurology (01-04-2023)
    “…Currently, disease-modifying therapies for multiple sclerosis (MS) use 4 mechanisms of action: immune modulation, suppressing immune cell proliferation,…”
    Get more information
    Journal Article
  4. 4

    Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression? by Geladaris, Anastasia, Torke, Sebastian, Weber, Martin S.

    Published in CNS drugs (01-10-2022)
    “…In multiple sclerosis (MS) persisting disability can derive from acute relapses or, alternatively, from slow and steady deterioration, termed chronic…”
    Get full text
    Journal Article
  5. 5

    The urgent need to address health literacy in schools by Okan, Orkan, Paakkari, Leena, Jourdan, Didier, Barnekow, Vivian, Weber, Martin W

    Published in The Lancet (British edition) (04-02-2023)
    “…The Editorial1 raised an important question: why is health literacy failing so many? It urgently called for effective responses to support people to better…”
    Get full text
    Journal Article
  6. 6

    Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function by Lehmann-Horn, Klaus, Kinzel, Silke, Weber, Martin S

    “…B cells, plasma cells and antibodies may play a key role in the pathogenesis of multiple sclerosis (MS). This notion is supported by various immunological…”
    Get full text
    Journal Article
  7. 7

    Emerging thin-film nanocomposite (TFN) membranes for reverse osmosis: A review by Zhao, Die Ling, Japip, Susilo, Zhang, Yu, Weber, Martin, Maletzko, Christian, Chung, Tai-Shung

    Published in Water research (Oxford) (15-04-2020)
    “…Thin-film composite (TFC) membranes are the heart of reverse osmosis (RO) processes for desalination and water reuse. In recent years, nanomaterials with high…”
    Get full text
    Journal Article
  8. 8

    The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders by Häusser-Kinzel, Silke, Weber, Martin S

    Published in Frontiers in immunology (08-02-2019)
    “…Our pathophysiological concept of the most common central nervous system demyelinating disease, multiple sclerosis, strikingly evolved by recent discoveries…”
    Get full text
    Journal Article
  9. 9

    Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis by Montalban, Xavier, Arnold, Douglas L, Weber, Martin S, Staikov, Ivan, Piasecka-Stryczynska, Karolina, Willmer, Jonathan, Martin, Emily C, Dangond, Fernando, Syed, Sana, Wolinsky, Jerry S

    Published in The New England journal of medicine (20-06-2019)
    “…In a randomized trial, patients who received evobrutinib, an inhibitor of Bruton’s tyrosine kinase, at 75 mg daily had significantly fewer enhancing lesions on…”
    Get full text
    Journal Article
  10. 10

    Credit Line Usage, Checking Account Activity, and Default Risk of Bank Borrowers by Norden, Lars, Weber, Martin

    Published in The Review of financial studies (01-10-2010)
    “…Information on borrower quality is a fundamental issue in debt contracting, corporate and consumer finance, and financial intermediation. We investigate the…”
    Get full text
    Journal Article
  11. 11

    CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation by Kowarik, Markus C, Cepok, Sabine, Sellner, Johann, Grummel, Verena, Weber, Martin S, Korn, Thomas, Berthele, Achim, Hemmer, Bernhard

    Published in Journal of neuroinflammation (16-05-2012)
    “…The chemokines and cytokines CXCL13, CXCL12, CCL19, CCL21, BAFF and APRIL are believed to play a role in the recruitment of B cells to the central nervous…”
    Get full text
    Journal Article
  12. 12

    Improving standards for primary care for children and adolescents in Europe, Central Asia and beyond: the WHO Pocket Book of Primary health care for children and adolescents by Carai, Susanne, Jullien, Sophie, Weber, Martin W.

    Published in Archives of disease in childhood (01-11-2022)
    “…Correspondence to Dr Susanne Carai, WHO Athens Quality of Care and Patient Safety Office, WHO Regional Office for Europe, Athens 10675, Greece; carais@who.int…”
    Get full text
    Journal Article
  13. 13

    Defining distinct features of anti-MOG antibody associated central nervous system demyelination by Weber, Martin S., Derfuss, Tobias, Metz, Imke, Brück, Wolfgang

    “…Extensive research over the last decades basically failed to identify a common cause of noninfectious inflammatory central nervous system (CNS) demyelinating…”
    Get full text
    Book Review Journal Article
  14. 14

    Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients by Traub, Jan, Häusser-Kinzel, Silke, Weber, Martin S

    “…B cells are considered major contributors to multiple sclerosis (MS) pathophysiology. While lately approved disease-modifying drugs like ocrelizumab deplete B…”
    Get full text
    Journal Article
  15. 15
  16. 16

    B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis by Nissimov, Nitzan, Hajiyeva, Zivar, Torke, Sebastian, Grondey, Katja, Brück, Wolfgang, Häusser-Kinzel, Silke, Weber, Martin S.

    “…B cell depletion via anti-CD20 antibodies is a highly effective treatment for multiple sclerosis (MS). However, little is known about the maturation/activation…”
    Get full text
    Journal Article
  17. 17

    Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression? by Geladaris, Anastasia, Häusler, Darius, Weber, Martin S

    “…Therapeutically controlling chronic progression in multiple sclerosis (MS) remains a major challenge. MS progression is defined as a steady loss of parenchymal…”
    Get full text
    Journal Article
  18. 18

    B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence by Kinzel, Silke, Weber, Martin S.

    Published in CNS drugs (01-12-2016)
    “…Over the last decade, evidence condensed that B cells, B cell-derived plasma cells and antibodies play a key role in the pathogenesis and progression of…”
    Get full text
    Journal Article
  19. 19

    Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies by Ochs, Jasmin, Häusser-Kinzel, Silke, Weber, Martin S.

    Published in Nature reviews. Immunology (01-09-2023)
    “…The transfer of surface molecules between cells by trogocytosis challenges the concept of cell type-unique surface markers and indicates that monoclonal…”
    Get full text
    Journal Article
  20. 20